Cellebrite DI Ltd. (CLBT) stock
Close on Nov 17, 2026Market cap $2.66BP/E 34.4Yield –
Earnings
Cellebrite DI's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Cellebrite DI's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 13, 2026before the open | $131.10M | +15.7% | $0.02 | $0.11 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 11, 2026before the open | – | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | $113.30M | +18.4% | $0.08 | $0.12 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 13, 2025before the open | $109.00M | +17.2% | $0.08 | $0.10 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 15, 2024before the open | $95.70M | +24.8% | -$0.12 | $0.10 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 15, 2024before the open | $93.00M | – | -$0.08 | $0.11 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | $76.70M | – | -$0.17 | $0.05 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 15, 2023before the open | – | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022before the open | – | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 16, 2022before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Cellebrite DI's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenue | Q3 FY2026 | $145.00M – $148.00M | – | New | Aug 13, 2026 |
| Adjusted EBITDAnon-GAAP | Q3 FY2026 | $42.00M – $45.00M | – | New | Aug 13, 2026 |
| ARR | Q3 FY2026 | $524.00M – $528.00M | – | New | Aug 13, 2026 |
| Revenue | FY2026 | $555.00M – $561.00M | – | New | Aug 13, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $153.00M – $159.00M | – | New | Aug 13, 2026 |
| ARR | FY2026 | $550.00M – $560.00M | – | New | Aug 13, 2026 |
Guidance history
Every forecast Cellebrite DI put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 13, 2026 | Adjusted EBITDA | Q3 FY2026 | $42.00M – $45.00M | New |
| Aug 13, 2026 | Adjusted EBITDA | FY2026 | $153.00M – $159.00M | New |
| Aug 13, 2026 | ARR | FY2026 | $550.00M – $560.00M | New |
| Aug 13, 2026 | ARR | Q3 FY2026 | $524.00M – $528.00M | New |
| Aug 13, 2026 | Revenue | FY2026 | $555.00M – $561.00M | New |
| Aug 13, 2026 | Revenue | Q3 FY2026 | $145.00M – $148.00M | New |
| Aug 14, 2025 | Adjusted EBITDA | FY2025 | $118.00M – $123.00M | Raised |
| Aug 14, 2025 | Adjusted EBITDA | Q3 FY2025 | $31.00M – $34.00M | New |
| Aug 14, 2025 | ARR | FY2025 | $460.00M – $475.00M | Lowered |
| Aug 14, 2025 | ARR | Q3 FY2025 | $435.00M – $445.00M | New |
| Aug 14, 2025 | Adjusted EBITDA margin | FY2025 | 25% – 26% | Raised |
| Aug 14, 2025 | Adjusted EBITDA margin | Q3 FY2025 | 26% – 27% | New |
| Aug 14, 2025 | Revenue | Q3 FY2025 | $121.00M – $126.00M | New |
| Aug 14, 2025 | Revenue | FY2025 | $465.00M – $475.00M | Lowered |
| Feb 13, 2025 | Adjusted EBITDA | FY2025 | $113.00M – $123.00M | New |
| Feb 13, 2025 | Adjusted EBITDA | Q1 FY2025 | $22.00M – $24.00M | New |
| Feb 13, 2025 | Adjusted EBITDA margin | Q1 FY2025 | 21% | New |
| Feb 13, 2025 | ARR | Q1 FY2025 | $406.00M – $411.00M | New |
| Feb 13, 2025 | Adjusted EBITDA margin | FY2025 | 24% – 25% | New |
| Feb 13, 2025 | ARR | FY2025 | $480.00M – $495.00M | New |
| Feb 13, 2025 | Revenue | Q1 FY2025 | $107.00M – $112.00M | New |
| Feb 13, 2025 | Revenue | FY2025 | $480.00M – $490.00M | New |
| Aug 15, 2024 | Adjusted EBITDA | FY2024 | $90.00M – $95.00M | Raised |
| Aug 15, 2024 | Adjusted EBITDA | Q3 FY2024 | $25.00M – $29.00M | New |
| Aug 15, 2024 | ARR | FY2024 | $388.00M – $400.00M | Raised |
| Aug 15, 2024 | Annual Growth | Q3 FY2024 | +24% – +27% | New |
| Aug 15, 2024 | ARR | Q3 FY2024 | $366.00M – $374.00M | New |
| Aug 15, 2024 | Adjusted EBITDA margin | FY2024 | 23% – 24% | New |
| Aug 15, 2024 | Annual Growth | FY2024 | +23% – +27% | Raised |
| Aug 15, 2024 | Adjusted EBITDA margin | Q3 FY2024 | 25% – 28% | New |
| Aug 15, 2024 | Annual Growth | Q3 FY2024 | +19% – +24% | New |
| Aug 15, 2024 | Revenue | Q3 FY2024 | $100.00M – $104.00M | New |
| Aug 15, 2024 | Annual Growth | FY2024 | +20% – +22% | Raised |
| Aug 15, 2024 | Revenue | FY2024 | $390.00M – $398.00M | Raised |
| Feb 15, 2024 | Adjusted EBITDA | FY2024 | $70.00M – $80.00M | New |
| Feb 15, 2024 | Adjusted EBITDA margin | Q1 FY2024 | 15% – 17% | New |
| Feb 15, 2024 | Adjusted EBITDA | Q1 FY2024 | $12.00M – $15.00M | New |
| Feb 15, 2024 | Adjusted EBITDA margin | FY2024 | 19% – 21% | New |
| Feb 15, 2024 | Annual Growth | Q1 FY2024 | +24% – +28% | New |
| Feb 15, 2024 | ARR | Q1 FY2024 | $325.00M – $335.00M | New |
| Feb 15, 2024 | Annual Growth | FY2024 | +20% – +27% | New |
| Feb 15, 2024 | ARR | FY2024 | $380.00M – $400.00M | New |
| Feb 15, 2024 | Revenue | FY2024 | $370.00M – $380.00M | New |
| Feb 15, 2024 | Annual Growth | FY2024 | +14% – +18% | New |
| Feb 15, 2024 | Revenue | Q1 FY2024 | $83.00M – $88.00M | New |
| Feb 15, 2024 | Annual Growth | Q1 FY2024 | +17% – +24% | New |
| Aug 8, 2023 | 2023 Adjusted EBITDA | FY2023 | $39.00M – $44.00M | New |
| Aug 8, 2023 | 2023 Adjusted EBITDA margin | FY2023 | 13% – 14% | New |
| Aug 8, 2023 | Growth over 2022 | FY2023 | +22% – +26% | New |
| Aug 8, 2023 | December 2023 ARR | FY2023 | $303.00M – $313.00M | New |
| Aug 8, 2023 | 2023 Revenue | FY2023 | $310.00M – $320.00M | New |
| Aug 8, 2023 | Growth over 2022 | FY2023 | +15% – +18% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Cellebrite DI filed with the SEC as exhibits to Form 8-K or 6-K
See a number that looks wrong?